The high negative predictive value of natriuretic peptides supports the more extensive use in identifying SSc patients with high risk of future cardiac involvement. PubMed, Clin Exp Rheumatol, 2014 Nov-Dec;32 Suppl 6(6):75-81. (Also see: Autoimmunity and Heart Disease)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.